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INTRODUCTION
Rickettsia conorii conorii is the aetiologic agent of
boutonneuse fever, also known as Mediterranean
spotted fever or Marseilles fever in the Mediter-
ranean area where it is endemic. The brown dog
tick, Rhipicephalus sanguineus, is recognised as the
principal vector of R. conorii [1,2]. Although a few
experimental studies have suggested transovarial
and transstadial transmission of R. conorii in
Rh. sanguineus [3], there are practically no data
available on the efﬁciency of such transmission or
on this vector–pathogen interaction. One recent
publication evaluated several methods for infect-
ing Rh. sanguineus with R. conorii, but reported
high mortality in infected ticks [4], which may
have resulted from incompatibility between the
particular rickettsial isolate and the source of
ticks used, or from the manipulation itself. In an
effort to establish a laboratory colony of
Rh. sanguineus persistently infected with R. conorii
for studying agent transmission, we assessed the
effects of R. conorii infection on the survival of
Rh. sanguineus larvae.
MATERIALS AND METHODS
Rickettsia conorii isolates of African (R. conorii conorii strain
Malish) and Mediterranean (R. conorii israelensis strain ISTT-
CDC1) origin were grown in Vero E6 cells and titred by plaque
assay on VERO E6 cells.
Cross-breed beagle dogs were inoculated intravenously
with c. 106 PFU of either Malish or ISTT strains of R. conorii. On
day 2 post-inoculation, they were infested with c. 3000 larvae
of Rh. sanguineus from either a North American (Oklahoma) or
Mediterranean (Israel) colony. Simultaneously, larvae from the
same colonies were placed upon uninfected dogs. Engorged
ticks were allowed to moult and freshly moulted nymphs were
fed upon uninfected C3H mice. Feeding success, moulting
success and the longevity of moulted ticks were assessed to
measure the effects of exposure to R. conorii on the survival of
Rh. sanguineus. Representative samples of unfed nymphs and
adult ticks were tested by PCR amplifying a 154-bp fragment
of the OmpA gene of Rickettsia as previously described [5].
RESULTS AND DISCUSSION
Rhipicephalus sanguineus larvae from both North
American and Mediterranean colonies fed upon
dogs infected with R. conorii conorii strain Malish
experienced high mortality during moulting, or
shortly after (Table 1). Only 16–18% of engorged
larvae survived through the moult. Rickettsial
DNA was detected in 4 out of 25 and in 1 out of 25
tested nymphs from the North American and
Mediterranean colonies, respectively. Nymphs
from both cohorts were short-lived and, if left
unfed, were all dead within 4 weeks. When
nymphs from these cohorts were further fed
upon C3H mice, their feeding success did not
exceed 20% (compared with 79–84% for unin-
fected nymphs), and only 61–75% of engorged
ticks moulted into the adult stage (compared with
98% for uninfected ticks). The pathogen was not
detected in resulting adult ticks, and none of the
C3H mice used for feeding developed antibodies
to R. conorii.
When ticks from both North American and
Mediterranean colonies were fed upon dogs
infected with Mediterranean R. conorii israelensis
strain ISTT-CDC1, the larval moulting success
and the longevity of unfed nymphs were more
similar to those in uninfected ticks (Table 1).
Rickettsial DNA was detected in 18 out of 50
and in 20 out of 50 tested nymphs from the
North American and the Mediterranean colonies,
respectively. When nymphs from these cohorts
were placed upon C3H mice, 68–72% of them fed
successfully to repletion, and 75% to 93% of
engorged ticks moulted into the adult stage. The
pathogen was detected in 10 out of 20 and 6 out of
20 resulting adult ticks from North American and
Mediterranean colonies, respectively. Differences
in the prevalence of infection were not statistically
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signiﬁcant between the two tick stocks. C3H mice
fed upon by nymphal ticks from both North
American and Mediterranean colonies developed
antibodies to R. conorii.
Exposure of Rh. sanguineus to R. conorii conorii
strain Malish produced lasting harmful effects on
their survival. These effects did not occur only
during or immediately after exposure, but also
during the following stages of the life-cycle.
Consequently, infection with R. conorii conorii
strain Malish was lost in ticks from both North
American and Mediterranean colonies within one
generation. In contrast, exposure of Rh. sanguineus
to R. conorii israelensis strain ISTT-CDC1 was not
as detrimental to ticks. Although the larval
moulting success was lower than in control ticks,
Rickettsia-exposed ticks from both colonies pro-
duced adults with a prevalence of infection of 30–
50%.
The negative effects of acquisition of the Malish
strain, but not the ISTT-CDC1 strain, on the
survival of ticks suggest that different strains of
R. conorii may exploit different routes of trans-
mission for maintenance in nature. Vertebrate
reservoirs may play a more prominent role in the
persistence of some strains of this agent than
previously thought. Foci of vector infection may
arise from recrudescence of the agent in the
vertebrate host and co-feeding transmission of
the agent between ticks may be an important
ampliﬁcation mechanism.
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Table 1. Survival of Rhipicephalus sanguineus larvae of different origin fed upon dogs inoculated with two strains of
Rickettsia conorii or uninfected dogs
Ticks fed upon
North American ticks Mediterranean ticks
No. ticks
engorged
No. ticks
moulted
(moulting
success, %)
Prevalence
of infection
in nymphs (%)
Longevity of
unfed nymphs
(weeks after
the moult)
No. ticks
engorged
No. ticks
moulted
(moulting
success, %)
Prevalence
of infection
in nymphs (%)
Longevity of
unfed nymphs
(weeks after
the moult)
Malish-infected dog 1156 209 (18 ± 2) 4 ⁄ 25 (16 ± 15) <4 1600 257 (16 ± 2) 1 ⁄ 25 (4 ± 8) <4
ISTT-CDC1-infected dog 1734 1337 (77 ± 2) 18 ⁄ 50 (36 ± 13) >10 1915 1240 (64 ± 2) 20 ⁄ 50 (40 ± 14) >10
Uninfected dogs 3599 3416 (94 ± 1) 0 ⁄ 50 (0) >10 2943 2449 (83 ± 1) 0 ⁄ 50 (0) >10
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